Packaging On Demand, Inc.
FDA inspection history in San Clemente, California, 2021 to 2023
- 2
- Form 483s
Every document, by year
- Form 483
2021: one Form 483; 2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2021–23Two Form 483s, at San Clemente, California.
- 2023The longest 483 on file: 9 observations over 8 pages at San Clemente, California.
Cited most
Across all Packaging On Demand observations on file
- 21 CFR 211.192Production record review3
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures3
- 21 CFR 211.180General requirements2
- 21 CFR 211.68Automatic, mechanical, and electronic equipment2
- 21 CFR 211.100(a)Written procedures; deviations1
The complete Packaging On Demand file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
San Clemente, California
Two Form 483s · 2021 to 2023 · 14 observations
Latest: Form 483, Jan 13, 2023 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-01-13 | 483 Form 483 | San Clemente, California | 9 | $99 |
| 2021-10-18 | 483 Form 483 | San Clemente, California | 5 | $99 |
Investigators on these documents
Jeffrey P. Raimondi (1)Khoa Nathan V. Tran (1)Lillian S. Wu (1)
FEI number 3004758248 · most recent document Jan 13, 2023
About Packaging On Demand, Inc.
How many FDA Form 483s has Packaging On Demand, Inc. received?
FDA Intel has 2 Form 483s on file for Packaging On Demand, Inc.; the most recent is dated Jan 13, 2023.
When was Packaging On Demand, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Packaging On Demand, Inc. is a Form 483 dated Jan 13, 2023, for the site in San Clemente, California.
What did FDA cite at Packaging On Demand, Inc.?
The regulations cited most in the observations on file for Packaging On Demand, Inc. are 21 CFR 211.192 (Production record review), 3 times; 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 3 times; 21 CFR 211.180 (General requirements), 2 times.